AT1 — Atomo Diagnostics Income Statement
0.000.00%
Last trade - 00:00- AU$20.70m
- AU$17.66m
- AU$3.79m
- 35
- 31
- 75
- 43
Annual income statement for Atomo Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.72 | 12.3 | 2.54 | 4.24 | 3.79 |
| Cost of Revenue | |||||
| Gross Profit | 3.42 | 4.25 | 0.667 | 1.76 | 1.92 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 12.8 | 18 | 12.5 | 11.1 | 8.75 |
| Operating Profit | -6.1 | -5.7 | -9.94 | -6.84 | -4.95 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.02 | -5.71 | -9.96 | -6.85 | -4.97 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.02 | -5.71 | -9.96 | -6.85 | -4.97 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.02 | -5.71 | -9.96 | -6.85 | -4.97 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.02 | -5.71 | -9.96 | -6.85 | -4.97 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.01 | -0.009 | -0.015 | -0.009 | -0.007 |